(Q34708024)

4 August 2017

Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors (English)

1 reference

4 August 2017

0 references

4

Irene L Andrulis

1 reference

4 August 2017

Sherry L Winter

1

1 reference

PubMed ID

17971899

4 August 2017

Lucine Bosnoyan-Collins

series ordinal

2

1 reference

PubMed ID

17971899

4 August 2017

Dushanthi Pinnaduwage

series ordinal

3

1 reference

4 August 2017

1 October 2007

1 reference

4 August 2017

1 reference

4 August 2017

9

1 reference

4 August 2017

10

1 reference

4 August 2017

797-800

1 reference

The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

Circadian gene mPer2 overexpression induces cancer cell apoptosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

Tumor suppression by the mammalian Period genes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

Night work and risk of breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

The circadian clock: pacemaker and tumour suppressor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

Night shift work, light at night, and risk of breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040206

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17971899

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1593/NEO.07595

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

PubMed ID

17971899